receiving and adhering to full doses of an appropriate antihypertensive drug regimen for a minimum of two weeks prior to screening.

agrees to have the study procedure(s) performed and additional procedures and evaluations, including repeat phlebotomy, imaging, urine analyses, and clinical examination.

competent and willing to provide written, informed consent to participate in this clinical study.

Exclusion Criteria:

renal arterial abnormalities

end stage renal disease requiring dialysis or renal transplant

serum Cr > 3, or calculated GFR < 45 ml/min

has experienced MI, unstable angina pectoris, or CVA with 6 months

others

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00483808